WUXIDAR4
Mark Identification

WUXIDAR4

Serial Number

90182832

Filing Date

Sep 15, 2020

Trademark by

WUXI BIOLOGICS CO. LTD.

Classification Information

Pharmaceutical preparations for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Drugs for medical purposes, namely, anticancer drugs; Biological preparations for medical purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Medicines for human purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Biochemical medicines for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Antibody drug for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Multispecific antibody for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Multispecific antibody format for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Medicines for veterinary purposes for treatment of canine disease; Biological preparations for veterinary purposes for treatment of canine disease

Pharmaceuticals

Biomanufacturing for others, namely, manufacturing of biopharmaceuticals using biological organisms in the manufacturing process; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Manufacturing services for others in the field of biopharmaceuticals

Treatment of Materials

Biomedical research services; Development of pharmaceutical preparations and medicines; Drug discovery services; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical research services; Product development for others; Product quality testing services; Product safety testing services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of new products for others; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Computer and Scientific